CD4+PF+ T cells with regulatory phenotype in B cell chronic lymphocytic leukaemia (B-CLL).

被引：0
|
作者：
Porakishvili, N
Jewell, AP
Kwee, Y
Akbar, A
Lydyard, PM
机构：
[1] Royal Free & UCL, Sch Med, London, England
[2] Kingston Univ, Sch Life Sci, Kingston upon Thames KT1 2EE, Surrey, England
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4982
引用
收藏
页码：356B / 356B
页数：1
相关论文
共 50 条
  • [31] Inhibition of T cell/B cell interaction by B-CLL cells
    C Kneitz
    M Goller
    M Wilhelm
    C Mehringer
    G Wohlleben
    A Schimpl
    H-P Tony
    Leukemia, 1999, 13 : 98 - 104
  • [32] Highly reproducible engraftment of human chronic lymphocytic leukaemia (B-CLL) cells in NOD/SCID spleens
    Ebeling, P.
    Duerig, J.
    Grabellus, F.
    Goethert, J.
    Seeber, S.
    Flasshove, M.
    Duehrsen, U.
    Moritz, T.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 63 - 63
  • [33] Inhibition of T cell B cell interaction by B-CLL cells
    Kneitz, C
    Goller, M
    Wilhelm, M
    Mehringer, C
    Wohlleben, G
    Schimpl, A
    Tony, HP
    LEUKEMIA, 1999, 13 (01) : 98 - 104
  • [34] Prognostic relevance of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL)
    D'Arena, G.
    Napolitano, M.
    Marcacci, G.
    Russo, F.
    Vigliotti, M. L.
    Mauro, F.
    Corazzelli, G.
    Frigeri, F.
    Della Cioppa, P.
    Svanera, G.
    Capobianco, G.
    Nasuti, A.
    Villani, O.
    Pinto, A.
    CYTOMETRY PART A, 2006, 69A (05) : 449 - 449
  • [35] Clinical significance of CD69 expression in B-cell Chronic Lymphocytic Leukemia (B-CLL)
    Del Poeta, G.
    Del Principe, M., I
    Luciano, F.
    Maurillo, L.
    Buccisano, F.
    Gattei, V
    Niscola, P.
    Venditti, A.
    Imo Consalvo, M.
    Catalano, G.
    de Fabritiis, P.
    Amadori, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 108
  • [36] Differential expression of CD180 and sIgM by B chronic lymphocytic leukaemia cells (B-CLL) using mutated and unmutated IgVh genes.
    Porakishvili, N
    Kulikova, N
    Manoussaka, M
    Jewell, AP
    Youinou, PY
    Nedelec, S
    Yong, K
    Nathwani, A
    Heelan, B
    Hamblin, T
    Wallace, P
    Ely, P
    Clarke, E
    Lydyard, PM
    BLOOD, 2004, 104 (11) : 768A - 768A
  • [37] Induction of an immunogenic and apoptotic phenotype in B chronic lymphocytic leukemia (B-CLL) cells by immunostimulatory PyNTTTTGT oligodeoxynucleotides (ODN).
    Dupont, J
    Flo, J
    Zorzopulos, J
    Riveros, D
    Lopez, R
    Garay, G
    Cacchione, R
    BLOOD, 2003, 102 (11) : 429A - 430A
  • [38] PHENYLACETATE IS CYTOTOXIC TO B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) CELLS
    CALL, TG
    STENSON, MJ
    WITZIG, TE
    BLOOD, 1993, 82 (10) : A561 - A561
  • [39] Aberrant expression of trail in B chronic lymphocytic leukemia (B-CLL) cells.
    Tiribelli, M
    Barbarotto, E
    Celeghini, C
    Michelutti, A
    Zauli, G
    Fanin, R
    Secchiero, P
    BLOOD, 2005, 106 (11) : 325B - 325B
  • [40] Autologous T cell targeting against aberrant antigen combinations in B cell chronic lymphocytic leukemia (B-CLL).
    Erben, U
    Bittroff-Leben, A
    Thiel, E
    Notter, M
    BLOOD, 2002, 100 (11) : 593A - 593A
12345